AMLX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 11.70%

Insider Buying (Last 12 Months): $326,397.50

Insider Selling (Last 12 Months): $494,508.16

Amylyx Pharmaceuticals Insider Trading History Chart

Amylyx Pharmaceuticals Share Price & Price History

^$3.55

▲ +0.09 (2.60%)

As of 10/11/2024 01:00 AM ET

Days: 30 | 90 | 365

Ex WH Advisor Who Predicted Biden Leaving Race Makes Startling New Prediction

From Paradigm Press | Ad

Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.

Click here to see it because it’s a SHOCKER…

Amylyx Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/30/2024	Camille L Bedrosian	Insider	Sell	11,442	$3.20	$36,614.40	143,801
9/30/2024	Justin B Klee	CEO	Sell	18,589	$3.20	$59,484.80	3,120,569
9/12/2024	James M Frates	CFO	Buy	40,000	$2.53	$101,200.00	233,464
9/3/2024	George M Milne Jr	Director	Buy	100,000	$2.20	$220,000.00	858,571
5/15/2024	Gina Mazzariello	Insider	Sell	10,455	$1.88	$19,655.40	151,477
5/14/2024	Daphne Quimi	Director	Buy	2,750	$1.89	$5,197.50	2,750
3/5/2024	Gina Mazzariello	Insider	Sell	1,540	$18.73	$28,844.20	81,372
3/5/2024	James M Frates	CFO	Sell	1,792	$18.73	$33,564.16	134,784
3/5/2024	Joshua B Cohen	CEO	Sell	4,135	$18.73	$77,448.55	3,023,002
2/23/2024	Gina Mazzariello	Insider	Sell	2,838	$18.76	$53,240.88	46,245
1/9/2024	James M Frates	CFO	Sell	2,716	$16.33	$44,352.28	112,035
1/9/2024	Justin B Klee	CEO	Sell	5,841	$16.33	$95,383.53	2,836,776
1/9/2024	Patrick D Yeramian	Insider	Sell	2,812	$16.33	$45,919.96	205,605
5/16/2023	James M Frates	CFO	Sell	32,500	$26.94	$875,550.00	55,676
5/15/2023	Patrick D Yeramian	Insider	Sell	11,965	$29.03	$347,343.95	208,417
4/17/2023	Patrick D Yeramian	Insider	Sell	49,579	$30.54	$1,514,142.66	208,417
3/29/2023	Morningside Venture Investment	Major Shareholder	Sell	29,048	$30.45	$884,511.60	6,997,302
3/27/2023	Morningside Venture Investment	Major Shareholder	Sell	60,964	$30.50	$1,859,402.00	7,126,350
3/21/2023	Morningside Venture Investment	Major Shareholder	Sell	63,448	$31.91	$2,024,625.68	7,187,314
3/16/2023	George M Milne Jr	Director	Sell	35,000	$31.89	$1,116,150.00	862,021
3/16/2023	James M Frates	CFO	Sell	32,500	$31.89	$1,036,425.00	1,509
3/16/2023	Justin B Klee	CEO	Sell	100,000	$31.86	$3,186,000.00	2,792,617
3/16/2023	Morningside Venture Investment	Major Shareholder	Sell	9,122	$32.55	$296,921.10	7,250,762
3/16/2023	Patrick D Yeramian	Insider	Sell	54,627	$31.87	$1,740,962.49	149,672
3/14/2023	Morningside Venture Investment	Major Shareholder	Sell	70,714	$34.54	$2,442,461.56	7,409,884
3/2/2023	Morningside Venture Investment	Major Shareholder	Sell	50,000	$33.75	$1,687,500.00	7,480,598
2/24/2023	Gina Mazzariello	Insider	Sell	3,586	$34.49	$123,681.14	37,414
2/22/2023	Morningside Venture Investment	Major Shareholder	Sell	50,000	$34.73	$1,736,500.00	7,530,598
9/8/2022	Global Investors Lp Viking	Major Shareholder	Sell	700,000	$29.37	$20,559,000.00	2,075,470

Kamala’s Dirty Election Move… Revealed

From Paradigm Press | Ad

According to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppet masters are planning this dirty election move…

Click here now and learn how to prepare.

SEC Filings (Institutional Ownership Changes) for Amylyx Pharmaceuticals (NASDAQ:AMLX)

95.84% of Amylyx Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Amylyx Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/16/2024	Point72 DIFC Ltd	25,953	$49K	0.0%	-47.0%	0.038%
9/16/2024	Cubist Systematic Strategies LLC	166,548	$0.32M	0.0%	-5.4%	0.245%
9/16/2024	Point72 Asia Singapore Pte. Ltd.	82,042	$0.16M	0.0%	N/A	0.121%
8/29/2024	Maven Securities LTD	100,000	$0.19M	0.0%	+300.0%	0.147%
8/16/2024	Algert Global LLC	24,814	$47K	0.0%	N/A	0.036%
8/16/2024	Almitas Capital LLC	1,903,851	$3.62M	1.5%	N/A	2.800%
8/15/2024	Mackenzie Financial Corp	57,923	$0.11M	0.0%	-20.2%	0.085%
8/15/2024	Millennium Management LLC	1,535,178	$2.92M	0.0%	-38.9%	2.257%
8/15/2024	AQR Capital Management LLC	3,340,943	$6.35M	0.0%	+2,768.0%	4.913%
8/15/2024	Point72 Asia Singapore Pte. Ltd.	82,042	$0.16M	0.0%	N/A	0.121%
8/14/2024	Squarepoint Ops LLC	272,576	$0.52M	0.0%	+71.1%	0.401%
8/14/2024	Cubist Systematic Strategies LLC	166,548	$0.32M	0.0%	-5.4%	0.245%
8/14/2024	Point72 DIFC Ltd	25,953	$49K	0.0%	-47.0%	0.038%
8/12/2024	XTX Topco Ltd	210,612	$0.40M	0.0%	N/A	0.310%
8/12/2024	Hsbc Holdings PLC	76,261	$0.15M	0.0%	+57.9%	0.112%
8/9/2024	Renaissance Technologies LLC	811,488	$1.54M	0.0%	+15.2%	1.193%
8/8/2024	American Century Companies Inc.	19,041	$36K	0.0%	-95.0%	0.028%
8/6/2024	Acadian Asset Management LLC	1,211,617	$2.30M	0.0%	N/A	1.782%
8/1/2024	Rhumbline Advisers	28,779	$55K	0.0%	-58.5%	0.042%
7/26/2024	Allspring Global Investments Holdings LLC	28,785	$55K	0.0%	+88.4%	0.042%
7/20/2024	Hennion & Walsh Asset Management Inc.	118,983	$0.23M	0.0%	+5.4%	0.175%
7/12/2024	SG Americas Securities LLC	55,836	$0.11M	0.0%	+113.6%	0.082%
7/10/2024	CWM LLC	28,643	$54K	0.0%	+104.2%	0.042%
5/24/2024	Farallon Capital Management LLC	1,150,221	$3.27M	0.0%	N/A	1.691%
5/15/2024	Price T Rowe Associates Inc. MD	970,555	$2.76M	0.0%	+8.5%	1.427%
5/10/2024	Vanguard Group Inc.	5,348,139	$15.19M	0.0%	+1.4%	7.864%
5/7/2024	Swiss National Bank	86,600	$0.25M	0.0%	+8.7%	0.127%
5/7/2024	SG Americas Securities LLC	26,139	$74K	0.0%	-60.4%	0.038%
5/1/2024	Capstone Investment Advisors LLC	80,084	$0.23M	0.0%	+300.4%	0.118%
4/30/2024	Allspring Global Investments Holdings LLC	15,276	$43K	0.0%	+52,575.9%	0.022%
4/18/2024	Allspring Global Investments Holdings LLC	15,276	$43K	0.0%	+52,575.9%	0.023%
4/17/2024	Hennion & Walsh Asset Management Inc.	112,867	$0.32M	0.0%	+32.9%	0.167%
3/1/2024	Goldman Sachs Group Inc.	1,256,861	$18.50M	0.0%	+5.9%	1.854%
2/26/2024	Virtu Financial LLC	27,715	$0.41M	0.0%	N/A	0.041%
2/26/2024	Perceptive Advisors LLC	1,869,125	$27.51M	0.6%	-30.5%	2.758%
2/14/2024	Avidity Partners Management LP	64,501	$0.95M	0.0%	-96.3%	0.096%
2/14/2024	Nebula Research & Development LLC	57,850	$0.85M	0.3%	+106.4%	0.086%
2/14/2024	Seven Eight Capital LP	66,801	$0.98M	0.1%	+11.5%	0.099%
2/14/2024	Sectoral Asset Management Inc.	84,055	$1.24M	0.5%	+14.1%	0.124%
2/13/2024	Stonepine Capital Management LLC	2,500,000	$36.80M	15.9%	-0.6%	3.703%
2/12/2024	Capstone Investment Advisors LLC	20,000	$0.29M	0.0%	-12.4%	0.030%
2/12/2024	TD Asset Management Inc	115,000	$1.69M	0.0%	N/A	0.170%
2/9/2024	Primecap Management Co. CA	156,900	$2.31M	0.0%	-48.5%	0.232%
2/9/2024	Franklin Resources Inc.	1,325,001	$19.50M	0.0%	+114.4%	1.962%
2/9/2024	Quest Partners LLC	6,035	$89K	0.0%	N/A	0.009%
2/9/2024	Trexquant Investment LP	265,046	$3.90M	0.1%	N/A	0.393%
2/9/2024	Dynamic Technology Lab Private Ltd	31,342	$0.46M	0.0%	-16.4%	0.046%
2/8/2024	Janney Montgomery Scott LLC	59,111	$0.87M	0.0%	+38.2%	0.088%
2/7/2024	Jump Financial LLC	13,343	$0.20M	0.0%	-41.6%	0.020%
2/6/2024	Charles Schwab Investment Management Inc.	387,620	$5.71M	0.0%	+5.9%	0.574%
2/6/2024	Swiss National Bank	79,700	$1.17M	0.0%	+19.8%	0.118%
2/5/2024	Russell Investments Group Ltd.	2,837	$42K	0.0%	-36.7%	0.004%
2/1/2024	New York State Common Retirement Fund	23,754	$0.35M	0.0%	+11.9%	0.035%
2/1/2024	Handelsbanken Fonder AB	11,900	$0.18M	0.0%	N/A	0.018%
1/31/2024	abrdn plc	195,493	$2.88M	0.0%	N/A	0.290%
1/31/2024	Federated Hermes Inc.	102,500	$1.51M	0.0%	-68.4%	0.152%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	10,389	$0.15M	0.0%	+69.4%	0.015%
1/30/2024	Cornercap Investment Counsel Inc.	44,487	$0.66M	0.1%	-5.6%	0.066%
1/30/2024	Strs Ohio	17,500	$0.26M	0.0%	N/A	0.026%
1/30/2024	Phocas Financial Corp.	86,073	$1.27M	0.2%	N/A	0.127%
1/24/2024	DekaBank Deutsche Girozentrale	83,000	$1.22M	0.0%	+151.5%	0.123%
1/24/2024	Arizona State Retirement System	11,302	$0.17M	0.0%	N/A	0.017%
1/24/2024	China Universal Asset Management Co. Ltd.	7,815	$0.12M	0.0%	+351.7%	0.012%
1/12/2024	Premier Path Wealth Partners LLC	20,265	$0.30M	0.1%	N/A	0.030%
1/12/2024	SG Americas Securities LLC	66,039	$0.97M	0.0%	+210.7%	0.098%
12/18/2023	Vanguard Group Inc.	5,050,080	$92.47M	0.0%	+2.5%	7.479%
12/7/2023	Hudson Bay Capital Management LP	682,223	$12.49M	0.1%	+134.5%	1.010%
11/22/2023	Graham Capital Management L.P.	56,241	$1.03M	0.0%	+84.1%	0.083%
11/15/2023	GSA Capital Partners LLP	42,435	$0.78M	0.1%	+203.0%	0.063%
11/15/2023	Sectoral Asset Management Inc.	73,655	$1.35M	0.3%	-81.0%	0.109%
11/15/2023	Seven Eight Capital LP	59,891	$1.10M	0.1%	N/A	0.089%
11/15/2023	Legacy Advisors LLC	50,000	$0.92M	0.1%	N/A	0.074%
11/15/2023	Adage Capital Partners GP L.L.C.	1,700,200	$31.13M	0.1%	+121.3%	2.518%
11/15/2023	AXQ Capital LP	10,836	$0.20M	0.1%	N/A	0.016%
11/15/2023	Axxcess Wealth Management LLC	26,151	$0.48M	0.0%	N/A	0.039%
11/14/2023	Schonfeld Strategic Advisors LLC	137,523	$2.52M	0.0%	-34.6%	0.204%
11/14/2023	Teza Capital Management LLC	23,594	$0.43M	0.0%	N/A	0.035%
11/14/2023	Avidity Partners Management LP	1,756,940	$32.17M	1.3%	+94.9%	2.602%
11/14/2023	Qube Research & Technologies Ltd	162,710	$2.98M	0.0%	+31.0%	0.241%
11/14/2023	Stonepine Capital Management LLC	2,515,868	$46.07M	15.3%	+124.4%	3.726%
11/14/2023	Primecap Management Co. CA	304,900	$5.58M	0.0%	N/A	0.452%
11/14/2023	Profund Advisors LLC	19,368	$0.36M	0.0%	+40.2%	0.029%
11/13/2023	Millrace Asset Group Inc.	19,496	$0.36M	0.4%	N/A	0.029%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	124,455	$2.28M	0.0%	N/A	0.184%
11/13/2023	Algert Global LLC	161,405	$2.96M	0.1%	N/A	0.239%
11/13/2023	Federated Hermes Inc.	324,260	$5.94M	0.0%	-78.8%	0.480%
11/13/2023	Healthcare of Ontario Pension Plan Trust Fund	122,130	$2.24M	0.0%	-26.9%	0.181%
11/13/2023	Dark Forest Capital Management LP	100,156	$1.83M	0.1%	+150.1%	0.148%
11/13/2023	Aigen Investment Management LP	65,863	$1.21M	0.2%	+99.2%	0.098%
11/13/2023	FMR LLC	438,686	$8.03M	0.0%	-2.3%	0.650%
11/13/2023	Rafferty Asset Management LLC	11,292	$0.21M	0.0%	N/A	0.017%
11/9/2023	Deutsche Bank AG	24,416	$0.45M	0.0%	-87.3%	0.036%
11/9/2023	Jupiter Asset Management Ltd.	649,736	$11.90M	0.1%	N/A	0.964%
11/8/2023	Charles Schwab Investment Management Inc.	365,862	$6.70M	0.0%	+12.4%	0.543%
11/8/2023	Janney Montgomery Scott LLC	42,784	$0.78M	0.0%	N/A	0.063%
11/8/2023	Swiss National Bank	66,500	$1.22M	0.0%	+1.7%	0.099%
11/7/2023	Virtus ETF Advisers LLC	12,223	$0.22M	0.1%	-11.5%	0.018%
11/7/2023	New York State Common Retirement Fund	21,235	$0.39M	0.0%	-9.0%	0.032%
11/7/2023	Barclays PLC	25,699	$0.47M	0.0%	-67.0%	0.038%
11/7/2023	Fox Run Management L.L.C.	16,985	$0.31M	0.1%	-5.6%	0.025%

Data available starting January 2016

Amylyx Pharmaceuticals, Inc., a commercial-stage biotechnology company, engages in the discovery and development of treatment for amyotrophic lateral sclerosis (ALS) and neurodegenerative diseases. The company's products include RELYVRIO, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of ALS in adults in the United States and marketed as ALBRIOZA for the treatment of ALS in Canada. It is also developing AMX0114 for other neurodegenerative diseases. Amylyx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $3.55

$3.44

$3.63

50 Day Range

MA: $2.55

$1.80

$3.55

52 Week Range

Now: $3.55

$1.58

$19.95

Volume

1,068,591 shs

Average Volume

2,048,168 shs

Market Capitalization

$241.42 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Amylyx Pharmaceuticals?: Amylyx Pharmaceuticals' top insider shareholders include:
Morningside Venture Investment (Major Shareholder)
Justin B Klee (CEO)
Joshua B Cohen (CEO)
George M Milne Jr (Director)
James M Frates (CFO)
Patrick D Yeramian (Insider)
Gina Mazzariello (Insider)
Camille L Bedrosian (Insider)
Daphne Quimi (Director)
Learn More about top insider investors at Amylyx Pharmaceuticals.